Chirag Talati, Espirito Santo Securities says the policy had been anticipated for long. According to him, Cipla, Cadila and Ranbaxy will be impacted negatively.
Drugs to treat a variety of disorders, especially lifestyle-related ones, will soon get cheaper by as much as 21 percent and it's all thanks to the new drug pricing policy that has just received cabinet approval.